STAAR names ex-CEO David Bailey Chief Commercial Officer; equity awards total $2.25M

STAAR SURGICAL CO

David Bailey named Chief Commercial Officer effective Sept 8, 2026, reporting to CEO Warren Foust; he was STAAR's President/CEO from 2001-2008 and later President, International.
Base salary CHF 462,825 (~$575,000); FY2026 target bonus 60% of salary, prorated; initial equity grant $850,000, 50% RSUs and 50% options vesting over three years.
2026 annual long-term incentive award valued at $1,400,000, prorated, split 50% options/50% RSUs; plus standard executive severance and change-in-control terms.
8-K/A corrects the equity award mix from the Sept 10, 2026 original filing; dollar amounts unchanged, corrected offer letter filed as Exhibit 10.1.
Press release cites Bailey's prior tenure: raised $60M+, won 2005 FDA approval of the ICL, launched in China and South Korea, and acquired the Canon Japan JV.

This headline and bullets were generated automatically by deepseek-v4.1-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.